InnoCare Pharma Limited

InnoCare Pharma Limited

INCPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.83B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
InnoCare Pharma LimitedInnoCare Pharma Limited12.8-16%1.60.3

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.83 Billion
Enterprise Value$-901,475,678.00
Earnings per Share$0.36
Beta0.39
Outstanding Shares1,767,202,139

Return

Return on Equity16.48%ROE
Return on Assets11.77%
Return on Invested Capital12.67%

Valuation & Multiples

P/E Ratio12.82P/E Ratio
PEG-0.98PEG
Price to Sales1.6Price to Sales
Price to Book Ratio0.4Price to Book Ratio
Enterprise Value to Revenue4.09
Enterprise Value to EBIT11.55
Enterprise Value to Net Income-1
Total Debt to Enterprise0.16
Debt to Equity0.26Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 27, 2026
EPS Estimate
-$0.04
Consensus analyst estimate
Revenue Estimate
$22.98 M
Consensus analyst estimate

Next Earnings Call

Expected Date
April 1, 2027
EPS Estimate
-$0.03
Consensus analyst estimate
Revenue Estimate
$162.58 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About InnoCare Pharma Limited

1,388 employees
CEO: Jisong Cui

InnoCare Pharma Limited, a biopharmaceutical enterprise, specializes in the discovery, development, and commercialization of therapeutic agents for oncological and autoimmune disorders. Its lead product, Orelabrutinib, a BTK inhibitor, a...

Questions & Answers